The Canadian Press - ONLINE EDITION
GlaxoSmithKline, Jiangsu Walvax Biotech form joint venture to produce vaccines for China
LONDON - Drugs maker GlaxoSmithKline Plc and Jiangsu Walvax Biotech Company said Tuesday they are forming a joint venture to develop and produce pediatric vaccines for measles, mumps and rubella (MMR) in China.
GSK said it would transfer technology for other vaccines to be produced by the joint venture, in which it would hold a 65 per cent interest and would initially invest 20.1 million pounds (US $30 million). It would invest a further 7.3 million pounds in 2015.
Walvax will invest a total of 13.8 million pounds, the announcement said.
Jiangsu Walvax is an affiliate of Yunnan Walvax Biotech Co., Ltd., China's second-largest manufacturer of Haemophilus influenza type b (Hib) conjugate vaccine.
"This collaboration will allow Walvax and GSK to produce lifesaving vaccines to help meet China's need for MMR vaccines," said Liu Hong-Yan, Chairman of Walvaxe. "The JV will strengthen our vaccine R&D efforts and build our capacity to increase children's access to vaccines, one of the most cost-effective health interventions available."
In June, GlaxoSmithKline also signed an agreement with Chinese biotech company Shenzhen Neptunus Interlong Bio-Technique Co., Ltd. to develop and manufacture flu vaccines.
GSK shares were up 0.9 per cent at 1,230 pence on the London Stock Exchange.
-
On the Net: http://www.gsk.com/
Fact Check
Have you found an error, or know of something we’ve missed in one of our stories? Please use the form below and let us know.
- Back to Top
- Return to Flu Fight
More Flu Fight
(1 of 2 articles for this year)
Haiti newspaper says health ministry notes human flu in DR, not avian flu, following Haiti ban
06/15/2013 5:30 PM 0PORT-AU-PRINCE, Haiti - A Haitian newspaper reported Saturday that a government official acknowledged authorities erred when they said the neighbouring ......
Poll
Most Popular Flu Fight
- Flu shots to be offered at 13 Winnipeg clinics
- South Africans detect H7N1 bird flu on ostrich farm, unrelated to Chinese killer strain
- Handwashing best defence against swine flu, but are all schools equipped?
- GlaxoSmithKline, Jiangsu Walvax Biotech form joint venture to produce vaccines for China
- Winnipeggers lining up to get seasonal flu shots
- Scientists say signs show new bird flu in China has likely mutated to infect other animals
- Surgical masks as good as N95 respirators for blocking flu in hospitals: study
- GlaxoSmithKline, Jiangsu Walvax Biotech form joint venture to produce vaccines for China
- Nursing shortages plague reserves
- Taiwan watching travellers from China closely after 1st H7N9 bird flu case surfaces on island
- Public Health Agency of Canada issues warning against travel to Mexico
- Flu shots to be offered at 13 Winnipeg clinics
- H1N1 wave ends; no sign of seasonal flu
- South Africans detect H7N1 bird flu on ostrich farm, unrelated to Chinese killer strain
- China WHO chief says new bird flu was expected to spread after 1st case reported in Beijing
- A new blow for pork industry
Ads by Google











You can comment on most stories on winnipegfreepress.com. You can also agree or disagree with other comments. All you need to do is be a Winnipeg Free Press print or e-edition subscriber to join the conversation and give your feedback.
You can comment on most stories on winnipegfreepress.com. You can also agree or disagree with other comments. All you need to do is be a Winnipeg Free Press print or e-edition subscriber to join the conversation and give your feedback.
Have Your Say
New to commenting? Check out our Frequently Asked Questions.
Have Your Say
Comments are open to Winnipeg Free Press print or e-edition subscribers only. why?
Login SubscribeHave Your Say
Comments are open to Winnipeg Free Press Subscribers only. why?
SubscribeThe Winnipeg Free Press does not necessarily endorse any of the views posted. By submitting your comment, you agree to our Terms and Conditions. These terms were revised effective April 16, 2010.